Skip to main content
OpenTrials

Clinical trial condition

Recurrent Ovarian Carcinoma

Explore clinical trials studying Recurrent Ovarian Carcinoma. Study availability and eligibility vary by location and protocol.

111 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Ovarian Carcinoma trial results

Completed

Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT02498600

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park Cameron Park, California, United States
View all 201 locations
View Trial Details
Completed

Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03206047

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 17 locations
View Trial Details

Related conditions